Two new ALS treatments now covered under Sask. drug plan
Saskatchewan residents with ALS may benefit from adding two new medications to the Saskatchewan Drug Plan Formulary. The Government of Saskatchewan announced that it is expanding treatment options for those living with ALS by listing Albrioza (sodium phenylbutyrate and ursodoxicoltaurine) and the oral suspension of Radicava (edaravone) on the Saskatchewan Drug Plan Formulary. Effective September […]